Inoculation of Human Tumor Cells Alters the Basal Expression but Not the Inducibility of Cytochrome P450 Enzymes in Tumor-Bearing Mouse Liver

The athymic nude mouse is often used to grow tumors for in vivo oncology research, including the identification of anticancer drugs, whereas wild-type mice are usually used to assess the pharmacokinetics (PK) of new chemical entities. The relationship between PK and pharmacodynamics (PD) provides useful mechanistic information and helps guide of the clinical regimen. The aim of this study was to assess whether the inoculation of human hepatocellular carcinoma cells (PLC/PRF/5) into athymic nude mice alters the expression of genes encoding the drug-metabolizing enzymes and transporters in host liver. The livers from nontumor- and tumor-bearing mice were initially subjected to drug metabolism gene microarray analysis. Microarray analysis indicated that tumor inoculation had little effect on drug metabolism-related genes, including several cytochrome P450s: Cyp1a, Cyp2b, and Cyp3a. This result was further confirmed by reverse transcription-polymerase chain reaction (RT-PCR). However, immunoreactive proteins of Cyp1a, Cyp2b, and Cyp3a were suppressed by tumor inoculation. RT-PCR and Western immunoblotting analysis showed that the inducibility of Cyp1a, Cyp2b, and Cyp3a by 3-methylcholanthrene, phenobarbital, and dexamethasone, respectively, was similar between nontumor- and tumor-bearing mice. These results suggest that inoculation of human tumor cells into athymic nude mice suppresses the expression of certain drug-metabolizing enzymes, which may alter the PK and PD of antitumor drugs.

[1]  J. Pohl,et al.  Dual Mechanisms of CYP3A Protein Regulation by Proinflammatory Cytokine Stimulation in Primary Hepatocyte Cultures , 2009, Drug Metabolism and Disposition.

[2]  A. Schinkel,et al.  PXR-mediated induction of human CYP3A4 and mouse Cyp3a11 by the glucocorticoid budesonide. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  D. Moore,et al.  Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR). , 2009, Toxicology.

[4]  A. El-Kadi,et al.  Role of NF-κB in the regulation of cytochrome P450 enzymes , 2009 .

[5]  Sang Chung,et al.  New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process , 2008, Journal of clinical pharmacology.

[6]  S. Verma,et al.  The Nuclear Factor-κB Pathway Regulates Cytochrome P450 3A4 Protein Stability , 2008, Molecular Pharmacology.

[7]  S. Clarke,et al.  Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies , 2007, British Journal of Cancer.

[8]  N. Hewitt,et al.  Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro–in vivo correlations , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  J. Schellens,et al.  The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology. , 2007, Cancer treatment reviews.

[10]  H. Hercule,et al.  Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. , 2007, The Biochemical journal.

[11]  I. Fidler,et al.  Murine models to evaluate novel and conventional therapeutic strategies for cancer. , 2007, The American journal of pathology.

[12]  G. Burckhardt,et al.  Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological Roles , 2007, Pharmaceutical Research.

[13]  S. Clarke,et al.  Transcriptional Repression of Hepatic Cytochrome P450 3A4 Gene in the Presence of Cancer , 2006, Clinical Cancer Research.

[14]  Tetsuo Takahashi,et al.  In vitro screening of 200 pesticides for agonistic activity via mouse peroxisome proliferator-activated receptor (PPAR)alpha and PPARgamma and quantitative analysis of in vivo induction pathway. , 2006, Toxicology and applied pharmacology.

[15]  B. Blumberg,et al.  Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. , 2006, The Journal of clinical investigation.

[16]  Jiunn H. Lin,et al.  CYP Induction-Mediated Drug Interactions: in Vitro Assessment and Clinical Implications , 2006, Pharmaceutical Research.

[17]  R. de Kanter,et al.  An in vivo and in vitro comparison of CYP gene induction in mice using liver slices and quantitative RT-PCR. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[18]  F. Lee,et al.  Prediction of Active Drug Plasma Concentrations Achieved in Cancer Patients by Pharmacodynamic Biomarkers Identified from the Geo Human Colon Carcinoma Xenograft Model , 2005, Clinical Cancer Research.

[19]  F. Lee,et al.  Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft , 2005, Cancer Chemotherapy and Pharmacology.

[20]  A. Kong,et al.  Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.

[21]  M. Martignoni,et al.  Lack of strain-related differences in drug metabolism and efflux transporter characteristics between CD-1 and athymic nude mice , 2005, Cancer Chemotherapy and Pharmacology.

[22]  S. Ekman,et al.  Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  Paolo Magni,et al.  Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents , 2004, Cancer Research.

[24]  J. Schenkman,et al.  Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. , 2003, Archives of biochemistry and biophysics.

[25]  D. Buckley,et al.  Induction of cytochrome P450 3A by paclitaxel in mice: pivotal role of the nuclear xenobiotic receptor, pregnane X receptor. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[26]  J. Boyer,et al.  Bile salt transporters: molecular characterization, function, and regulation. , 2003, Physiological reviews.

[27]  B. Teicher,et al.  Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology , 2003, Cancer Chemotherapy and Pharmacology.

[28]  B. Teicher,et al.  Site-dependent angiogenic cytokine production in human tumor xenografts. , 2003, Cytokine.

[29]  B. Rolstad.  The athymic nude rat: an animal experimental model to reveal novel aspects of innate immune responses? , 2001, Immunological reviews.

[30]  A. Jazieh,et al.  Cancer Therapy and Polymorphisms of Cytochromes P450 , 2000, Clinical chemistry and laboratory medicine.

[31]  A. Simpson.  The cytochrome P450 4 (CYP4) family. , 1997, General pharmacology.

[32]  R. Novak,et al.  Posttranscriptional elevation of cytochrome P450 3A expression. , 1997, Biochemical and biophysical research communications.

[33]  W. Backes,et al.  Induction of P450 3A by ethylbenzene without altering RNA levels. , 1994, Biochemical and biophysical research communications.

[34]  B. Teicher,et al.  Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. , 1990, Science.

[35]  J. Denekamp,et al.  Site dependent response of tumours to combined heat and radiation. , 1982, British Journal of Radiology.

[36]  Toshiyuki Fukutomi,et al.  Mouse organic anion transporter 2 (mOat2) mediates the transport of short chain fatty acid propionate. , 2008, Journal of pharmacological sciences.

[37]  S. Verma,et al.  The Nuclear Factor-B Pathway Regulates Cytochrome P 450 3 A 4 Protein Stability , 2008 .

[38]  S. Arkle,et al.  Regulation and induction of CYP3A11, CYP3A13 and CYP3A25 in C57BL/6J mouse liver. , 2007, Archives of biochemistry and biophysics.

[39]  A. Favier,et al.  Antioxidant status and lipid peroxidation in athymic mice xenografted with two types of human tumors , 2007, Biological Trace Element Research.

[40]  K. Nakata,et al.  Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems. , 2006, Drug metabolism and pharmacokinetics.

[41]  I. Blanca,et al.  Influence of inoculation site on development of the Lewis lung carcinoma and suppressor cell activity in syngeneic mice. , 1979, Journal of the National Cancer Institute.